The introduction of Retatrutide ZPHC, at a strength of 120mg, is creating considerable excitement within the healthcare community. This groundbreaking dual GIP and GLP-1 agonist medication appears to offer notable improvements in fat shedding compared to previous therapies. Preliminary research data have demonstrated substantial decreases in weight